2011 Annual Meeting | Therapy of Stroke

Date Thursday 04/14/11

Time 03:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Bruce I. Ovbiagele, MD, MSc, FAAN

Topic(s)

Learning Objectives Participants should be knowledgeable about the optimal management of acute cerebral infarction, including general medical strategies, thrombolytic treatment, endovascular therapy, and surgical approaches, as well as their relevant therapeutic windows; and develop a logical framework for promptly implementing various vascular risk reduction strategies after acute or recent cerebral ischemia including selection of antithrombotic agents, lipid modifiers, antihypertensive therapies, and revascularization procedures.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:00 PM - 03:45 PM		Evidence-Based Management of Acute Ischemic Stroke in 2011 Pooja Khatri, MD, FAAN
03:00 PM - 05:00 PM		Break
03:45 PM - 04:30 PM		How to Prevent 2/3rds of All Strokes: New Trials and New Approaches Mark J. Alberts, MD, FAAN
04:30 PM - 05:00 PM		Questions and Answers Mark J. Alberts, MD, FAAN, Pooja Khatri, MD, FAAN

Faculty Disclosures
Mark J. Alberts, MD, FAAN	No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Pooja Khatri, MD, FAAN	The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��